 EVAR for small AAAs (< 5cm) shows improved long term outcomes than for age-matched patients with larger aneurysms  Less Type I endoleaks, fewer secondary procedures, better 10 year survival Small AAA Clinical trials  Current smoking increased risk of expansion by 25%.
 Because mean survival was not different with the two strategies, ultrasonographic surveillance until the aneurysm reaches a diameter of more than 5.5 cm is a reasonable strategy Study Overview PIVOTAL  Since EVAR is safer than open repair for large AAA; randomized trial of early EVAR for small AAA Vs surveillance.  4-5cm AAA to EVAR Vs ultrasound surveillance.  31% ultimately underwent repair during surveillance.  At a mean follow-up of 20 months, ACM was 4.1% in both groups.  Rupture or ARM was 0.6% in both groups. This was lower than expected in the surveillance group so enrollment was stopped.  Early EVAR and rigorous surveillance with selective aneurysm treatment are both safe alternatives preventing ARM for at least 3 years. 
